SMSbiotech Receives FDA Clearance for Inhaled Stem Cell Therapy COPD Trial
The blood-derived, off-the-shelf cells are administered directly to the lungs through a standard nebulizer, with first U.S. patient dosing targeted for late 2026.
Pulmonary News
New Trial – Autologous Lung Progenitor Cells for COPD
Regend Therapeutics plans a Phase 3, randomized, blinded, placebo-controlled study enrolling 102 people with COPD and emphysema to assess lung diffusion capacity at 52 weeks.
FibroBiologics Studying Fibroblast Treatment for Hantavirus
The company is expanding its preclinical work on acute respiratory syndrome to investigate whether its fibroblasts may help with deadly lung inflammation, vascular leakage, and tissue damage.
RION Partners with Lonza for Large-Scale Production of Stem Cell-Derived Exosome Therapies
The partnership will support clinical and future commercial supply of RION’s exosome therapies for tissue repair and regenerative medicine.
CIRM Approves $73 Million for Early-Stage Regenerative Medicine Research in California
The new grants will support diverse early-stage research projects, aiming to advance regenerative medicine tools and future therapies.
Stem Cell-Derived Extracellular Vesicles Show Promise for Respiratory Disease
Researchers are exploring whether stem cell-derived extracellular vesicles could offer safer, targeted therapies for respiratory diseases, but technical hurdles remain.
Stem Cell Trial: iPSCs for Repairing Airway Damage in COPD
The study will test whether induced pluripotent stem cells can help repair airway damage in people with COPD.
Stem Cell Trial: Umbilical Cord MSCs to Prevent Lung Disease in Preterm Infants
Researchers will test if umbilical cord stem cell infusions can safely reduce lung disease in extremely premature infants.
First patient dosed in Idopathic Pulmonary Fibrosis peptide Phase 2 from Rein Therapeutics
The Phase 2 trial RCT will evaluate adverse event and efficacy endpoints.